Groundbreaking Preclinical Data on TN301 A Potential Breakthrough in Treating HFpEF
Tenaya Therapeutics has recently unveiled groundbreaking preclinical data in Nature Communications on their novel small molecule HDAC6 inhibitor, TN-301, designed ...